Thermo Fisher Scientific (TMO) : Hills Bank Trust Co reduced its stake in Thermo Fisher Scientific by 0.63% during the most recent quarter end. The investment management company now holds a total of 19,381 shares of Thermo Fisher Scientific which is valued at $3,083,711 after selling 123 shares in Thermo Fisher Scientific , the firm said in a disclosure report filed with the SEC on Oct 11, 2016.Thermo Fisher Scientific makes up approximately 1.12% of Hills Bank Trust Co’s portfolio.
Other Hedge Funds, Including , Pacwest Financial Management Inc reduced its stake in TMO by selling 380 shares or 3.79% in the most recent quarter. The Hedge Fund company now holds 9,638 shares of TMO which is valued at $1,533,502. Thermo Fisher Scientific makes up approx 0.94% of Pacwest Financial Management Inc’s portfolio.Central Bank Trust Co reduced its stake in TMO by selling 46 shares or 19.74% in the most recent quarter. The Hedge Fund company now holds 187 shares of TMO which is valued at $29,585. Thermo Fisher Scientific makes up approx 0.01% of Central Bank Trust Co’s portfolio.Telemus Capital boosted its stake in TMO in the latest quarter, The investment management firm added 1,625 additional shares and now holds a total of 26,242 shares of Thermo Fisher Scientific which is valued at $4,153,584. Thermo Fisher Scientific makes up approx 0.46% of Telemus Capital’s portfolio.North Star Asset Management Inc reduced its stake in TMO by selling 828 shares or 1.81% in the most recent quarter. The Hedge Fund company now holds 44,964 shares of TMO which is valued at $7,116,902. Thermo Fisher Scientific makes up approx 0.80% of North Star Asset Management Inc’s portfolio.Cullinan Associates Inc boosted its stake in TMO in the latest quarter, The investment management firm added 3,270 additional shares and now holds a total of 21,780 shares of Thermo Fisher Scientific which is valued at $3,447,338. Thermo Fisher Scientific makes up approx 0.30% of Cullinan Associates Inc’s portfolio.
Thermo Fisher Scientific closed down -4.21 points or -2.65% at $154.9 with 26,97,528 shares getting traded on Tuesday. Post opening the session at $156, the shares hit an intraday low of $153.79 and an intraday high of $156.585 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, Thermo Fisher Scientific reported $2.03 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $2.01. The company had revenue of $4535.20 million for the quarter, compared to analysts expectations of $4493.28 million. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.84 EPS.
Many Wall Street Analysts have commented on Thermo Fisher Scientific. JP Morgan Resumed Thermo Fisher Scientific on Sep 22, 2016 to “Overweight”, Price Target of the shares are set at $180.Thermo Fisher Scientific was Downgraded by Cleveland Research to ” Neutral” on Sep 9, 2016.
Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.